Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Futu Holdings Ltd (FUTU) vs Smith & Nephew plc (SNN) Price & Performance

Futu Holdings LtdTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Futu Holdings Ltd vs Smith & Nephew plc — how do they compare? Futu Holdings Ltd trades at $110 (market cap $15.38B), while Smith & Nephew plc trades at $27.08 (market cap $11.31B). The key difference: Futu Holdings Ltd is the larger of the two by market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Futu Holdings Ltd for 34 Days and Smith & Nephew plc for 120 Days on average.

FUTUSNN
Market Cap
$15.38B$11.31B
Volume
1,475,1161,050,005
Sector
FinancialsHealth
52-Week High
$199.04$37.17
52-Week Low
$89.76$26.42
Typical Hold Time
34 Days120 Days
Enterprise Value
$15.73B$14.35B
Dividend Yield
2.37%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Futu Holdings Ltd

Futu Holdings (FUTU) trades at $108.76, down 3.93% on the day amid a bearish technical signal, though it remains above key support near $107. The company reported strong Q2 2026 earnings with a beat on EPS of $3.33 versus $2.98 expected, continuing robust revenue growth that reached $22.85 billion in 2025. However, a securities class action lawsuit deadline on August 25, 2026, adds near-term uncertainty.

The outlook is mixed: solid fundamentals with a low P/E of 10.95 and high net margin of 42.92% support upside potential, but technical weakness and legal overhangs pose risks. Analyst consensus is bullish with a 33.7% upside target, yet investors must weigh growth against litigation and market sentiment pressures.

Smith & Nephew plc

SNN trades at $26.96, near its 52-week low, with a bearish technical signal. The company has shown improving fundamentals, with revenue growing from $5.2B in 2022 to $6.16B in 2025 and net income margin expanding to 10.08%. Recent product launches, like the EVOS PELVIC System, highlight innovation, but the stock faces negative sentiment from analyst downgrades and CFO departure news.

The outlook is mixed: strong profitability and cash flow support value, but bearish technicals and cautious analyst consensus (26% buy, 65% hold) suggest limited near-term upside. Key risks include execution challenges and competitive pressures. Investors should weigh solid fundamentals against weak market sentiment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FUTU
0% Buy100% Sell
Avg holding period · 34 Days
SNN

No sentiment data available yet.

About Futu Holdings Ltd

Futu Holdings Ltd is an online broker providing one-stop online investing services. The company provides its services through its digital platform Futu NiuNiu, which includes market data, trading service, and news feed of Hong Kong, Mainland China, Singapore, and United States equity markets. It generates its revenue in the form of brokerage commission and handling charge services.

Read more on FUTU →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →